Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial-Reference-Cited by-同舟云学术

Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial

Published:2023-11 Issue:11 Volume:29 Page:708.e1-708.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Ram Ron^ORCID,Amit Odelia,Adler Amos^ORCID,Bar-On Yael,Beyar-Katz Ofrat,Avivi Irit,Shasha David,Ben-Ami Ronen^ORCID

Funder

Pfizer

Merck

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference21 articles.

1. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America;Freifeld;Clin Infect Dis,2011

2. Management of fever in neutropenic patients with different risks of complications;Klastersky;Clin Infect Dis,2004

3. Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation;Betticher;Hematol Oncol,2021

4. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

5. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia;Averbuch;Haematologica,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic toxicity of CAR-T therapy and potential monitoring indicators for toxicity prevention;Frontiers in Immunology;2024-08-26

2. Antibiotic practice and stewardship in the management of neutropenic fever: a survey of US institutions;Infection Control & Hospital Epidemiology;2024-08-01

3. Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting;Transplantation and Cellular Therapy;2024-07

4. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07